Propofol injections purchased by DHB hospitals from 2015/16

OIA response

 

Thank you for your request dated 5 April 2022 under the Official Information Act 1982 (OIA) for information relating to propofol. You requested: 

the purchasing in DHB’s of the different formulations of propofol (including 20ml, 50ml, and 100ml) for …  2015/16 through to 2020/21 

Table 1: Total injections purchased by DHB hospitals per financial year[1]

Formulation 2015/16 2016/17 2017/18 2018/19 2019/20 2020/21
Inj 10 mg per ml, 100 ml vial 8,548 16,554 16,060 24,686 24,836 41,930
Inj 10 mg per ml, 20 ml ampoule 54,611   20 150 143,075 228,996
Inj 10 mg per ml, 20 ml vial 248,125 305,055 310,725 304,100 223,905 39,395
Inj 10 mg per ml, 50 ml syringe 710 392 115 1,018 25  
Inj 10 mg per ml, 50 ml vial 91,347 107,604 141,110 167,885 184,233 180,438
Injection 50mL, 10mg/mL 5          
Total injections 403,346 429,605 468,030 497,839 576,074 490,759

 Please note:

  1. Figures are based on purchase data provided by DHBs. Pharmac makes no representation as to the accuracy of the figures provided.
  2. Data includes units reported by DHBs as extracted on 26 April 2022.
  3. Purchases included relate to the Combined Pharmaceutical Budget only. Therefore, these figures may exclude additional purchases relating to COVID-19. 

We trust that this information answers your queries. We are making our information more freely available, so we now publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this.

[1] Pharmac's financial year runs from 1 July to 30 June.